These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10458088

  • 21. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
    Otero ME, van den Reek JM, Seyger MM, van de Kerkhof PC, Kievit W, de Jong EM.
    Br J Dermatol; 2017 Aug; 177(2):497-504. PubMed ID: 28078672
    [Abstract] [Full Text] [Related]

  • 22. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J, Simková M, Vanecková J, Hroch M, Chládkova J, Martínková J, Vávrová J, Beránek M.
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [Abstract] [Full Text] [Related]

  • 23. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 24. Koebner Phenomenon in Juvenile Dermatomyositis.
    Tidwell WJ, Callen JP.
    J Rheumatol; 2018 Mar; 45(3):437. PubMed ID: 29496916
    [No Abstract] [Full Text] [Related]

  • 25. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B, Saraswat A, Kaur I.
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [Abstract] [Full Text] [Related]

  • 26. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy.
    Khopkar U, Bhor U.
    Indian J Dermatol Venereol Leprol; 2008 Jul; 74(4):379-82. PubMed ID: 18797063
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS, Costner MI.
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Impotence caused by Methotrexate treatment].
    Penninga EI, Larsen HK, Andersen SE.
    Ugeskr Laeger; 2008 Jan 28; 170(5):354. PubMed ID: 18252170
    [Abstract] [Full Text] [Related]

  • 34. Methotrexate and liver function: a study of 13 psoriasis cases treated with different cumulative dosages.
    Carneiro SC, Cássia FF, Lamy F, Chagas VL, Ramos-e-Silva M.
    J Eur Acad Dermatol Venereol; 2008 Jan 28; 22(1):25-9. PubMed ID: 18181969
    [Abstract] [Full Text] [Related]

  • 35. The value of methotrexate in dermatomyositis.
    Zieglschmid-Adams ME, Pandya A, Cohen SB, Sontheimer RD.
    J Am Acad Dermatol; 1998 Jan 28; 38(1):130-2. PubMed ID: 9448226
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nodulosis in systemic onset juvenile idiopathic arthritis: an uncommon event with spontaneous resolution.
    Abdwani R, Scuccumarri R, Duffy K, Duffy CM.
    Pediatr Dermatol; 2009 Jan 28; 26(5):587-91. PubMed ID: 19840317
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.